Skip to main content
Premium Trial:

Request an Annual Quote

Mexican Magnate Provides $65M for Broad Partnership

NEW YORK (GenomeWeb News) – The Carlos Slim Institute of Health has pledged $65 million to a partnership with the Broad Institute of MIT and Harvard and the National Institute for Genomic Medicine in Mexico for genomics-focused disease studies, Broad said today.

The partnership will focus on genomic sequencing and related projects aimed at understanding cancer and diabetes, and it will be funded by the Carlos Slim Institute of Health, which was founded in 2007 by Mexican business magnate Carlos Slim Helú. The effort will be primarily administered by The Mexican Secretariat of Health's NIGM.

Called the Slim Initiative for Genomic Medicine, the three-year project will create catalogs of genetic mutations linked to cancer, and it will assemble systematic descriptions of the genetic factors underlying type 2 diabetes.

The cancer studies will develop knowledge about genetic mutations that may be used to pursue new cancer therapies and pharmacogenomic tools to identify which patients may respond to specific drugs.

Diabetes is a common inherited disease in Latin America, and the project will aim to develop knowledge of the genetic risk factors in the region's population.

"I am convinced that only through genomics will we be able to face the costly burden of illnesses that strain the budgets of even the richest countries," Slim said in a statement.

"Carlos Slim is making a visionary commitment to public health in the Americas in two ways, Broad Institute Director and President Eric Lander said. "First, in recognizing that progress in public health must be built on a foundation of scientific understanding of the genetic basis of disease. Second, in recognizing that deepening the scientific ties between the US and Mexico can have great benefits for both countries."

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.